Unlicensed GS-441524-Like Antiviral Therapy Can Be Effective for at-Home Treatment of Feline Infectious Peritonitis
The goal of this study was to formally evaluate the administration of unlicensed, crowd-sourced antiviral GS-441524-like therapy for cats suspected to have feline infectious peritonitis (FIP), a previously fatal disease. Members of a large social media support and GS-441524-like drug distribution gr...
Main Authors: | Sarah Jones, Wendy Novicoff, Julie Nadeau, Samantha Evans |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | Animals |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-2615/11/8/2257 |
Similar Items
-
Combination Therapy with Fluoxetine and the Nucleoside Analog GS-441524 Exerts Synergistic Antiviral Effects against Different SARS-CoV-2 Variants In Vitro
by: Linda Brunotte, et al.
Published: (2021-09-01) -
Peritonite infecciosa felina: Revisão
by: Isabela Lopes Massitel, et al.
Published: (2021-01-01) -
Cellular Uptake and Intracellular Phosphorylation of GS-441524: Implications for Its Effectiveness against COVID-19
by: Henrik Berg Rasmussen, et al.
Published: (2021-07-01) -
Can remdesivir and its parent nucleoside GS-441524 be potential oral drugs? An in vitro and in vivo DMPK assessment
by: Jiashu Xie, et al.
Published: (2021-06-01) -
Possible Antiviral Activity of 5-Aminolevulinic Acid in Feline Infectious Peritonitis Virus (Feline Coronavirus) Infection
by: Tomomi Takano, et al.
Published: (2021-02-01)